159 related articles for article (PubMed ID: 28968497)
21. Preclinical evaluation of [
Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
[TBL] [Abstract][Full Text] [Related]
22. Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB
Heimann D; Börgel F; de Vries H; Patberg M; Jan-Smith E; Frehland B; Schepmann D; Heitman LH; Wünsch B
Eur J Med Chem; 2018 Feb; 146():409-422. PubMed ID: 29407967
[TBL] [Abstract][Full Text] [Related]
23. Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies.
Spinelli F; Capparelli E; Abate C; Colabufo NA; Contino M
J Med Chem; 2017 Dec; 60(24):9913-9931. PubMed ID: 28608697
[TBL] [Abstract][Full Text] [Related]
24. Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [
Ueberham L; Gündel D; Kellert M; Deuther-Conrad W; Ludwig FA; Lönnecke P; Kazimir A; Kopka K; Brust P; Moldovan RP; Hey-Hawkins E
J Med Chem; 2023 Apr; 66(7):5242-5260. PubMed ID: 36944112
[TBL] [Abstract][Full Text] [Related]
25. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands.
Kallinen A; Mardon K; Lane S; Montgomery AP; Bhalla R; Stimson DHR; Ahamed M; Cowin GJ; Hibbs D; Werry EL; Fulton R; Connor M; Kassiou M
ACS Chem Neurosci; 2023 Aug; 14(16):2902-2921. PubMed ID: 37499194
[TBL] [Abstract][Full Text] [Related]
27. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
[TBL] [Abstract][Full Text] [Related]
28. A Novel Selective Inverse Agonist of the CB
Martella A; Sijben H; Rufer AC; Grether U; Fingerle J; Ullmer C; Hartung T; IJzerman AP; van der Stelt M; Heitman LH
Mol Pharmacol; 2017 Oct; 92(4):389-400. PubMed ID: 28747489
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imaging.
LeSarge JC; Thibeault P; Yu L; Childs MD; Mirka VM; Qi Q; Fox MS; Kovacs MS; Ramachandran R; Luyt LG
Eur J Med Chem; 2023 Jan; 246():114989. PubMed ID: 36527934
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging.
Haider A; Müller Herde A; Slavik R; Weber M; Mugnaini C; Ligresti A; Schibli R; Mu L; Mensah Ametamey S
Front Neurosci; 2016; 10():350. PubMed ID: 27512365
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.
Evens N; Vandeputte C; Muccioli GG; Lambert DM; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Bioorg Med Chem; 2011 Aug; 19(15):4499-505. PubMed ID: 21737287
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor.
Slavik R; Grether U; Müller Herde A; Gobbi L; Fingerle J; Ullmer C; Krämer SD; Schibli R; Mu L; Ametamey SM
J Med Chem; 2015 May; 58(10):4266-77. PubMed ID: 25950914
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of novel (18)F-labeled spirocyclic piperidine derivatives as σ1 receptor ligands for positron emission tomography imaging.
Li Y; Wang X; Zhang J; Deuther-Conrad W; Xie F; Zhang X; Liu J; Qiao J; Cui M; Steinbach J; Brust P; Liu B; Jia H
J Med Chem; 2013 May; 56(9):3478-91. PubMed ID: 23566245
[TBL] [Abstract][Full Text] [Related]
34. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
[TBL] [Abstract][Full Text] [Related]
35. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
36. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.
Litau S; Niedermoser S; Vogler N; Roscher M; Schirrmacher R; Fricker G; Wängler B; Wängler C
Bioconjug Chem; 2015 Dec; 26(12):2350-9. PubMed ID: 26420336
[TBL] [Abstract][Full Text] [Related]
37. Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB
Aly MW; Ludwig FA; Deuther-Conrad W; Brust P; Abadi AH; Moldovan RP; Osman NA
Bioorg Chem; 2021 Sep; 114():105191. PubMed ID: 34375194
[TBL] [Abstract][Full Text] [Related]
38. 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.
Lucchesi V; Parkkari T; Savinainen JR; Malfitano AM; Allarà M; Bertini S; Castelli F; Del Carlo S; Laezza C; Ligresti A; Saccomanni G; Bifulco M; Di Marzo V; Macchia M; Manera C
Eur J Med Chem; 2014 Mar; 74():524-32. PubMed ID: 24518874
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue.
Haider A; Spinelli F; Herde AM; Mu B; Keller C; Margelisch M; Weber M; Schibli R; Mu L; Ametamey SM
Eur J Med Chem; 2018 Feb; 145():746-759. PubMed ID: 29353725
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
